<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-102947</identifier>
<setSpec>1134-928X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Diaper rash. Local treatment with barrier products and quality of life</dc:title>
<dc:description xml:lang="en">The skin disorders are derived in most cases continuous injuries by external factors that have how responses the loss of epidermal lipids by the effect of moisture, derived of changes in skin pH (alkalinization), an increased coefficient of friction (denudation) and the imbalance of the saprophytic flora of the skin, give how a result an increase to the irritative processes and the fungal and bacterian infections in the area exposed to moisture. Given the importance of assessing the quality of life of patients with dermatitis who are treated with No Sting Barrier Film (NSBF) CavilonTM has developed a multicenter study, in order to evaluate the related to improving the quality of care that patients Incontinence Dermatitis with ESCLI scale. Patients included in the study were 25. The results show a significant improvement aspects ESCLI assessed by the scale of the evolution of the dermatitis. This scale assesses aspects such as the area affected by the redness and severity. Show a reversal 47% of cases. The denudation of the skin in the diaper area disappears in 56% of cases and the severity of the denudation which has a 47% improvement. The assessment of pain in the area of incontinence, is reduced by 76% in the area of incontinence and a 73% when cleaning the area. The findings of this study prove indicates that the application of forming products of a No Sting Barrier Film (NSBF) in patients with incontinence dermatitis is an alternative to conventional treatments such as creams or ointments or zinc oxide paste water. The reversal and reduction of dermatitis is an aspect that has improved important. The results that we can relate to quality of life or longer specifically with the improvement of pain are significant (AU)</dc:description>
<dc:creator>Rueda López, Justo</dc:creator>
<dc:creator>Muñoz Bueno, A. M</dc:creator>
<dc:creator>Segovia Gómez, T</dc:creator>
<dc:creator>Rosell Moreno, C</dc:creator>
<dc:creator>Bermejo Martínez, M</dc:creator>
<dc:creator>Guerrero Palmero, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los trastornos cutáneos son derivados, en la mayoría de las ocasiones, de agresiones continuas por elementos externos que tiene como respuesta reacciones como la pérdida de lípidos epidérmicos por efecto de la humedad, cambios en el pH cutáneo (alcalinización) y aumento del coeficiente de fricción (denudación) junto al desequilibrio de la flora saprofita de la piel, que se traducen en procesos irritativos y en un aumento de la infecciones fúngicas y bacterianas en la zona expuesta a humedad. Dada la importancia de evaluar la calidad de vida de los pacientes con dermatitis que son tratados con productos barrera no irritantes (PBNI) se ha desarrollado un estudio multicéntrico, con el objetivo de evaluar los aspectos relacionados con la mejora en la calidad de cuidados a pacientes tratados con Cavilon® que presentaban dermatitis por incontinencia mediante la escala ESCLI. Los pacientes incluidos en el estudio fueron 25. Los resultados muestran una mejora importante de los aspectos evaluados mediante la escala ESCLI  (..) (AU)</dc:description>
<dc:source>Gerokomos (Madr., Ed. impr.);23(1): 35-41, mar. 2012. ilus, tab</dc:source>
<dc:identifier>ibc-102947</dc:identifier>
<dc:title xml:lang="es">Dermatitis irritativa del pañal. Tratamiento local con productos barrera y calidad de vida</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d33519^s22073</dc:subject>
<dc:subject>^d14949^s22012</dc:subject>
<dc:subject>^d12225</dc:subject>
<dc:subject>^d3990^s22054</dc:subject>
<dc:subject>^d31040^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d3894^s22054</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:type>article</dc:type>
<dc:date>201203</dc:date>
</metadata>
</record>
</ibecs-document>
